Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

NovaBay Pharmaceuticals (NBY) Tax Provisions (2016 - 2020)

Historic Tax Provisions for NovaBay Pharmaceuticals (NBY) over the last 12 years, with Q4 2020 value amounting to $4000.0.

  • NovaBay Pharmaceuticals' Tax Provisions rose 3333.33% to $4000.0 in Q4 2020 from the same period last year, while for Sep 2021 it was $4000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $5000.0 for FY2020, which is 1666.67% down from last year.
  • Per NovaBay Pharmaceuticals' latest filing, its Tax Provisions stood at $4000.0 for Q4 2020, which was up 3333.33% from $1000.0 recorded in Q2 2020.
  • NovaBay Pharmaceuticals' Tax Provisions' 5-year high stood at $4000.0 during Q4 2020, with a 5-year trough of $1000.0 in Q1 2017.
  • Moreover, its 5-year median value for Tax Provisions was $2000.0 (2016), whereas its average is $2000.0.
  • Its Tax Provisions has fluctuated over the past 5 years, first plummeted by 6666.67% in 2016, then surged by 10000.0% in 2019.
  • Quarter analysis of 5 years shows NovaBay Pharmaceuticals' Tax Provisions stood at $2000.0 in 2016, then changed by 0.0% to $2000.0 in 2017, then skyrocketed by 50.0% to $3000.0 in 2018, then changed by 0.0% to $3000.0 in 2019, then surged by 33.33% to $4000.0 in 2020.
  • Its Tax Provisions was $4000.0 in Q4 2020, compared to $1000.0 in Q2 2020 and $3000.0 in Q4 2019.